CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Can Table Salt Supercharge Your Immune System to Fight Cancer?

    The Cancer Research Institute (CRI) is excited to share the latest study from CRI Lloyd J. Old…
    August 28, 2024| Ajit Muley, PhD
  • Mucinomics: The Sweet Solution to Fighting Cancer

    Mucinomics is the study of a class of proteins called mucins. We try to leverage changes in…
    August 27, 2024| Max Mallet
  • How Immunotherapy Before Surgery Can Impact Patient Outcomes

    For some cancer patients, immunotherapy can serve as a first-line treatment, while for others it can act…
    August 27, 2024| Max Mallet
  • How Molecular Imaging and Nuclear Radiology Arm Scientists to Fight Cancer

    Immunotherapy research propels scientific progress and helps patients live longer, healthier lives using the human immune system…
    August 26, 2024| Max Mallet
  • How CAR T Cell Therapy is Pushing the Boundaries of Cancer Treatment

    Adoptive cellular therapy is a branch of immunotherapy that channels the body’s cancer-fighting cells to eliminate the…
    August 21, 2024| Max Mallet
  • How Immunotherapy Saved Laurie’s Life

    “I would run as fast as I can to get immunotherapy, because the results are so much…
    August 21, 2024| Max Mallet
  • Five Things to Know When Considering Immunotherapy

    When former U.S. President Jimmy Carter credited immunotherapy for beating his cancer in 2015, it was a…
    August 20, 2024| Max Mallet
  • Tecelra® Receives FDA Approval: A New Milestone in Cancer Treatment

    On August 2, 2024, the U.S Food and Drug Administration (FDA) approved Tecelra® (afamitresgene autoleucel), a gene…
    August 15, 2024| Ajit Muley, PhD
  • ImmunoAdvocate Perspectives: Navigating Cancer Immunotherapy and Survivorship

    Sharing one’s cancer survival story is not just a personal act of courage — it has the…
    August 15, 2024| Max Mallet
Previous Page
1 … 4 5 6 7 8 … 91
Next Page
Father and son

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

See ways to give
CRI Logo

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute